By: Akanksha Verma
Nephrocare Health IPO Day 2: The grey market premium or the Nephrocare IPO GMP stood at Rs 20, projecting 4.35 per cent gain over the price band. The listing price is estimated to be Rs 480.
India (National)


Not enough data
Akanksha Verma's coverage focuses primarily on Indian politics, state governments, chief ministers, elections, and government policies. With a national focus on India, she is likely to be interested in pitches related to evolving political stories or breaking news in the Indian political landscape.
Given her emphasis on government announcements and evolving stories within politics and society, Akanksha may be receptive to experts who can provide insightful commentary or analysis on ongoing developments in Indian politics. Pitches offering exclusive interviews with key political figures or informed perspectives on emerging trends could also capture her attention.
Considering her extensive coverage of state-specific events and policymakers across India, pitches should align with this regional focus while addressing current affairs within the country's diverse political landscape.
This information evolves through artificial intelligence and human feedback. Improve this profile .